Kovack Advisors, Inc. Stereotaxis, Inc. Transaction History
Kovack Advisors, Inc.
- $919 Million
- Q3 2024
A detailed history of Kovack Advisors, Inc. transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Kovack Advisors, Inc. holds 123,875 shares of STXS stock, worth $289,867. This represents 0.03% of its overall portfolio holdings.
Number of Shares
123,875
Previous 223,776
44.64%
Holding current value
$289,867
Previous $407,000
38.08%
% of portfolio
0.03%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding STXS
# of Institutions
89Shares Held
41.1MCall Options Held
139KPut Options Held
20.6K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$32 Million7.17% of portfolio
-
Lagoda Investment Management, L.P. New York, NY3.83MShares$8.96 Million4.5% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$8.29 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$7.24 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.79MShares$6.53 Million6.12% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $175M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...